Replies to post #207517 on Biotech Values

[rkrw]

He is the Steve Jobs of Life Sciences.....according to unnamed renowned scientists anyway.

https://pixarbio.com/management-team/frank-reynolds/

From an email investment solicitation they made last year

"I can't think of another CEO in Pharma that has invented, funded and capitalized on more neurological inventions since 2005 than me, so I'm am Banking on the Best Jockey in the Business, Me, or as my investors have called me "Frank the Bank!""

Not surprisingly InVivo sued him in 2014 for a bunch of things.

http://www.bizjournals.com/boston/blog/bioflash/2014/03/invivo-reveals-lawsuit-against-former-ceo-in.html

[DewDiligence]

PXRB was joking about NVIV bid, evidently:

https://finance.yahoo.com/news/pixarbio-corporation-terminates-invivo-therapeutics-110000863.html

NVIV is +1%, which makes sense insofar as the threat of a takeunder has been lifted, LOL.

[DewDiligence]

SEC halts trading in PXRB through 2/3/17:

http://finance.yahoo.com/news/pixarbio-corporation-securities-temporarily-suspended-202200378.html

PixarBio is currently in the process of providing the SEC with documentation. “We were shocked to have the SEC suspend trading of our stock earlier this week, and we are looking forward to a successful review by the SEC” said PixarBio CEO Frank Reynolds. Reynolds continued “Whatever third parties were responsible for the SEC’s actions shall not stop our future plans to replace addictive opiates in the market.

LMAO